Home  |  Contact Us  |   Register for Updates  |   Site Map

A new paradigm in medicine — integrating therapeutics and diagnostics for better care

Prometheus is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Our strategy includes the marketing and delivery of proprietary diagnostic testing services and pharmaceutical products. By integrating these, Prometheus believes it can provide physicians with more targeted solutions to optimize care for their patients.

Please select a category :
IBD
PROMETHEUS®

7C4 Diagnostic Test


Measures 7α-hydroxy-4-cholesten-3-one (7C4) levels to help determine if bile acid malabsorption (BAM) may be the underlying cause of patients' gastrointestinal-related symptoms.

* Available in all states except New York (pending).
7C4 Diagnostic Test
PROMETHEUS®

Monitr™
Crohn's Disease


Provides a unique combination of 13 biomarkers to assess mucosal healing in adult Crohn's disease (CD) patients.
Learn more about Monitr™.
PROMETHEUS Monitr
PROMETHEUS®

IBD sgi Diagnostic®


+ See more about
IBD sgi Diagnostic®
Combines serologic, genetic, and inflammation markers to help differentiate IBD vs non-IBD and ulcerative colitis (UC) vs Crohn's disease (CD).
PROMETHEUS IBD sgi Diagnostic<sup>®</sup>
PROMETHEUS®

Crohn's Prognostic


+ See more about
Crohn's Prognostic
Evaluate the probability of disease progression in a CD patient by providing a personal serogenetic profile.
Crohns Prognostic
BIOLOGIC
MONITORING
PROMETHEUS®

Anser® IFX



+ See more about Anser® IFX
Simultaneously measures infliximab (IFX) and antibodies to infliximab (ATI) levels in serum at any time during therapy. Can also be used with IFX biosimilars.
Visit www.anserifx.com for detailed information.
Anser-IFX
PROMETHEUS®

Anser® ADA



+ See more about Anser® ADA
Simultaneously measures adalimumab (ADA) and antibodies to adalimumab (ATA) levels in serum at any time during therapy.
Visit www.anserada.com for detailed information.
Anser-ADA
PROMETHEUS®

Anser® UST



Simultaneously measures ustekinumab (UST) and antibodies to ustekinumab (UST) levels in serum at any time during therapy.
Visit www.anserust.com for detailed information.
Anser-UST
PROMETHEUS®

Anser® VDZ



+ See more about Anser® VDZ
Simultaneously measures vedolizumab (VDZ) and antibodies to vedolizumab (ATV) levels in serum at any time during therapy.
Visit www.anservdz.com for detailed information.
Anser-VDZ
CELIAC
PROMETHEUS®

Celiac Plus


+ See more about
Celiac Plus
Combines serologic, genetic, and inflammation markers to help identify active celiac disease and stratify relative risk.
Visit www.celiacplus.com for detailed information.
Celiac
PROMETHEUS®

Celiac Genetics


+ See more about
Celiac Genetics
Analyzes a patient's genetic profile for disease risk stratification.
PROMETHEUS®

Celiac Serology


+ See more about
Celiac Serology
Comprehensive serum antibody profile combines 5 serological markers (IgG, IgA, tTG, EMA, and total serum IgA) as an aid in the diagnosis of celiac disease.
THIOPURINE
MANAGEMENT
PROMETHEUS®

TPMT Genetics


+ See more about
TPMT Genetics
Genotypes a patient to aid in individualizing a starting dose of thiopurines. Ordering prior to inititating therapy provides information for effective dosing, which may acheive maximum efficacy with minimized toxicity.
Thiopurine Testing
PROMETHEUS®

TPMT Enzyme


+ See more about
TPMT Enzyme
Phenotypes a patient to aid in individualizing a starting dose of thiopurines. Ordering prior to inititating therapy provides information as an aid for effective dosing, which may acheive maximum efficacy with minimized toxicity.
Thiopurine Testing
PROMETHEUS®

Thiopurine Metabolites


+ See more about
Thiopurine Metabolites
Results can be used as an aid in optimization of ongoing dosing of thiopurines in order to reach and maintain a desired clinical response.
Thiopurine Monitoring
LIVER
PROMETHEUS®

FIBROSpect® HCV


Noninvasively aids in the detection, staging, and monitoring of the severity of liver fibrosis for hepatitus C virus (HCV) patients.
Learn more about FIBROSpect® HCV.
fibrospect
PROMETHEUS®

FIBROSpect® NASH


Noninvasively aids in the detection, staging, and monitoring of liver fibrosis for nonalcoholic steatohepatitus (NASH) patients.
Learn more about FIBROSpect® NASH.
fibrospect
OTHER
PROMETHEUS®

LactoTYPE®

Genetics test as an aid in the identification of primary lactase nonpersistence.
PROMETHEUS®

NOD2/CARD15

For prognostic information in patients diagnosed with Crohn’s disease.
Home  |  Contact Us  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Legal and Compliance  |  Notice of Privacy Practices  |  ProNet  |  Outside the US
Prometheus tests are laboratory-developed tests that were developed and validated under Federal CLIA laboratory guidelines, and are performed exclusively by Prometheus Laboratories Inc.

This material is provided for general information purposes only, as an educational service for healthcare physicians and their patients. It is not intended as a substitute for medical advice and/or consultation with a physician.

Reference within this site to any specific advertisement or promotion of a non-Prometheus product does not constitute an endorsement or recommendation by Prometheus.
© 2019 Prometheus Laboratories Inc, San Diego, California. All rights reserved.